Plus Therapeutics, Inc. | CYTX - Net Income


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Plus Therapeutics, Inc.

Plus Therapeutics, Inc. reported $-5658000 in Net Income for its fiscal quarter ending in December of 2022.


Net Income Change
Baxter International BAX:US USD 44M 137M
Dr.Reddys Laboratories DRRD:IN INR 9.59B 2.85B
Haemonetics HAE:US USD 29.38M 3.56M
Infinity Pharmaceuticals INFI:US USD -11045000 1.82M
Merrimack Pharmaceuticals MACK:US USD -271000 221K
Mirati Therapeutics MRTX:US USD -184586000 17.89M
Northwest Biotherapeutics NWBO:US USD -10652000 17.65M
Starpharma Holdings Ltd SPL:AU AUD -8277000 572K
Sun Pharmaceuticals SUNP:IN INR 19.84B 1.82B
Teva Pharmaceutical Industries Ltd TEVA:IT USD -206000000 1.02B